Literature DB >> 34872141

Association of Overweight and Consistent Anovulation among Infertile Women with Regular Menstrual Cycle: A Case-control Study.

Christiane Ricaldoni Giviziez1, Eliane Gouveia de Morais Sanchez1, Yanna Andressa Ramos de Lima2, Mário Silva Approbato2.   

Abstract

OBJECTIVE: It has been suggested that excess body weight could represent a risk factor for infertility outcomes. The present study aimed to evaluate the association of overweight and anovulation among infertile women with regular menstrual cycles.
METHODS: We conducted a retrospective case-control study with consistently anovulatory patients undergoing assisted reproduction treatment. The patients were stratified into normal weight (body mass index [BMI]: 18.5-24.9kg/m2) and overweight (BMI: 25.0-29.9kg/m2).Those with polycystic ovary syndrome or obesity were excluded. The groups were matched for age, duration of infertility, prolactin, follicle stimulating hormone (FSH), thydroid stimulating hormone (TSH), luteinizing hormone (LH), and estradiol levels.
RESULTS: Overweight was significantly associated with anovulation, when using the World Health Organization (WHO) criteria for anovulation: progesterone levels > 5.65 ng/ml and ultrasonography evidence of follicle collapse (odds ratio [OR]: 2.69; 95% confidence interval [CI95%]: 1.04-6.98).
CONCLUSION: Body mass index above the normal range jeopardizes ovulation among non-obese infertile women with regular menstrual cycles. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34872141     DOI: 10.1055/s-0041-1739464

Source DB:  PubMed          Journal:  Rev Bras Ginecol Obstet        ISSN: 0100-7203


  2 in total

1.  Fertility-enhancing effect of oil-based contrast agents during hysterosalpingography and the variation of this effect within a 3-year follow-up period in infertile patients.

Authors:  Jingyuan Lu; Dan Qi; Wenjian Xu
Journal:  Front Med (Lausanne)       Date:  2022-08-29

2.  The FIGO Ovulatory Disorders Classification System†.

Authors:  Malcolm G Munro; Adam H Balen; SiHyun Cho; Hilary O D Critchley; Ivonne Díaz; Rui Ferriani; Laurie Henry; Edgar Mocanu; Zephne M van der Spuy
Journal:  Hum Reprod       Date:  2022-09-30       Impact factor: 6.353

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.